openPR Logo
Press release

Chronic Idiopathic Constipation Market Research Report 2024

04-19-2017 04:57 PM CET | Health & Medicine

Press release from: Transparency Market Research

Chronic Idiopathic Constipation Market Research Report 2024

Constipation can be defined as reduced stool frequency or difficulty in passing stool. The frequency may be reduced to less than three times a week. Reduced or difficult stool passage includes hard lumpy stools, incomplete bowel movements, straining, incomplete evacuation, and need for manual removal of stool. Chronic idiopathic constipation (CIC) can be defined as more chronic or severe continuation of these above symptoms. Many times the cause of constipation is unclear or unknown and not because of underlying illness or medication. As cause of constipation is unclear, it is called idiopathic constipation. Often chronic idiopathic constipation is indicated with multiple symptoms. The repeatedly occurring most common symptoms include abdominal discomfort, bloating, gas pain, incomplete evacuation, hard stool, and straining at the time of bowel movement.

Get Sample Copy of this Report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20537

Chronic idiopathic constipation occurs without an identifiable cause. Several factors contribute to constipation including change in water balance and motility in colon. The rate at which muscles in colon contract to help pass through the stool is referred as motility. If colon absorbs more water, the stool can be hard, dry, and difficult to pass. The infrequent bowel movement could be due to dry, hard stool leading to chronic idiopathic constipation. If motility is slower down, the stool movement can be difficult to pass which results in infrequent bowel movement. This slow movement results in more water absorption and leads to hard, dry stool. A survey found chronic idiopathic constipation common in 56% women, 44% men. It has been observed more common in adult aged or older people. Out of patients suffering from chronic idiopathic constipation only 12% are medically diagnosed and 40% are actively seeking treatment. Increasing incidence, prevalence, and growing awareness can be considered the major factors driving the global chronic idiopathic constipation treatment market. Rising prescription opioid consumption, increasing geriatric population, rising health care expenditure, launch of targeted medicines, and growing awareness are likely to drive the chronic idiopathic constipation treatment market during the forecast period.

The global chronic idiopathic constipation treatment market has been segmented based on type, type of administration, region, and distribution channel. In terms of type, the market has been segmented into pharmacological treatment and non-pharmacological treatment. Pharmacological treatment consists of stool softener, laxatives, bulk forming agents, emollients, osmotic agents, chloride channel activators, and others. Based on type of administration, the global chronic idiopathic constipation treatment market has been categorized into oral and parenteral. In terms of distribution channel, the market has been divided into independent pharmacies, drug stores, and hospital pharmacies. The data obtained from the National Center for Biotechnology Information revealed that 4 million people in the U.S. have frequent constipation, corresponding to prevalence of 2%. The laxatives and stool softeners segments are expected to account for major share of the global chronic constipation market during the forecast period in comparison to other class of drugs.

Geographically, the global chronic idiopathic constipation treatment market has been segmented into five key regions: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to hold major share of the chronic idiopathic constipation treatment market owing to significant percentage of population suffering from CIC. Europe was the second largest market for chronic idiopathic constipation treatment due to high prevalence rate. India, China, and Japan are likely to fuel the growth of the global chronic idiopathic constipation market in Asia Pacific. Abbott Gut-Health Survey reported that 14% people in India suffer from constipation. Mexico and Brazil are the high potential growth markets in Latin America because of improvement of medical infrastructure.

Major players in the global chronic idiopathic constipation treatment market include Boehringer Ingelheim GmbH, Bayer AG, C. B. Fleet Company, Inc., Daewoong Co. Ltd., Synergy Pharmaceuticals, Inc., Actavis, Ironwood Pharmaceuticals, Cosmo Pharmaceuticals, and Sucampo Pharmaceuticals, Inc.

View Report @ http://www.transparencymarketresearch.com/chronic-idiopathic-constipation-treatment-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chronic Idiopathic Constipation Market Research Report 2024 here

News-ID: 507856 • Views: 323

More Releases from Transparency Market Research

Analysis of COVID-19 Crisis-driven Growth Opportunities in Water Pump Market- St …
The inorganic growth of businesses reduces the competition between the sector in the market for water pumps. New product growth, technological developments in products and acquisitions by worldwide conglomerates of smaller players are characteristic for the industry of water pumps. Obtain Report Details @ https://www.transparencymarketresearch.com/water-pump-market.html But tiny, unorganized players who are able to develop and market economically efficient products to serve increasing customer pools in the emerging economies also face less serious
TMR Analyzes Impact of Outbreak of COVID-19 on FPSO Equipment Market Statistics, …
The global floating production storage and offloading FPSO market is competitive and segmented. Transparency Market Research Market (TMR) report states that there are a few major players in the industry who are relentlessly developing new and innovative designs to penetrate the global market during the forecast period. Obtain Report Details @ https://www.transparencymarketresearch.com/FPSO-vessels-equipments-market.html These prominent players are focused on introducing new strategies like collaborations and partnerships to provide new in the global
Analysis of Potential Impact of COVID-19 on Medical Nutrition Market - Industry …
Medical Nutrition Market: Complementarity of Pharmacology & Nutrition to Augur Well for Growth As old health rules are overturned, a physiological approach that starts from health in place of disease is gaining high emphasis. Hippocrates quote, ‘Let food be thy medicine and medicine be thy food’ has been put into practice, as individuals are considering medical nutrition and food for enhancing health and treating disease, despite the developments procured in the
Biotech Flavors Market Valuation to reach US$ 3 Bn by 2029
According to a new study by TMR, the sales of biotech flavors are estimated to reach 134,422 metric tons in 2019. The biotech flavors market is projected to record a Y-o-Y growth of ~9% during the forecast period. Growth of the biotech flavors market remains driven by a slew of aspects, which range from increased market demand for clean label products and changing regulations in the food and beverage industry,

All 5 Releases


More Releases for Chronic

Narcotic Analgesics: Future of Chronic Pain Management
The development of tolerance for non-narcotic analgesics is the primarily reason behind the constantly increasing sales for narcotic analgesics. Attributing to the higher efficacy in pain management and quick onset of action, narcotic analgesics are largely used in palliative care services for treating patients suffering from neuropathic pain. Increasing focus on palliative care services in third world countries and readily available reimbursements are the key factors expected to boost the
Global Chronic Bacterial Prostatitis Market Research Report
Latest industry research report on: Global Chronic Bacterial Prostatitis Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts GlobalData's clinical trial report, Chronic Bacterial Prostatitis Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Bacterial Prostatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Bacterial Prostatitis. Report includes an overview of trial numbers and their average
Boot chronic pain
For immediate release Due to our rushed lives and stressful environment, many people are suffering from chronic pain and fatigue. We feel permanently tired and are barely able to get through our normal day. One is able to change this status when following the guidelines the book "Tired of being Tired to the point of being Gatvol (Fed Up). Some people will need a team of medical practitioners to help them
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow
Chronic Pancreatitis Pain Market: mostly driven by increasing number of chronic …
Chronic pancreatitis is a long term inflammation of pancreas which leads to permanent damage and digestion capability of pancreas. Most common symptoms include severe abdominal pain, diabetes, weight loss, producing greasy and foul-smelling stools etc. Common cause associated with chronic pancreatitis is heavy alcohol consumption. Other causes include hereditary disorders of pancreas, gall stones, cystic fibrosis, certain medication etc. CT scan, magnetic resonance cholangiopancreatography, ultrasound sonography are diagnostic tests used
Targeting chronic pain
With the support of the Austrian Science Fund FWF, the neurophysiologist Ruth Drdla-Schutting is investigating the role astrocytes play in the genesis of chronic pain. With the help of innovative gene technology (DREADDs), scientists are tailoring treatment specifically to these cells that are the most numerous found in the central nervous system. Pain is an important protection system of the human body. But when it becomes chronic, as it frequently